The PredART study—published in the New England Journal of Medicine—showed that a four-week course of moderate dose prednisone reduced the risk of TB-IRIS by 30% in HIV-positive patients at high risk.
Older patients and those with lower body weight may need to be carefully monitored during linezolid treatment.
Community stakeholders representing various Khayelitsha-based organisations gathered to consult with CIDRI-Africa’s clinical research team on future tuberculous meningitis research.
Maia will develop novel statistical methods for analysis of complex study data on lung health in Africa.
+27 (0)21 406 6797
Institute of Infectious Disease
and Molecular Medicine
University of Cape Town
Supported by the Wellcome Trust (203135/Z/16/Z)